What Researchers Did
The authors wrote a review of treatments for Helicobacter pylori that do not rely on drugs, including hyperbaric oxygen therapy.
What They Found
This narrative review outlines how Helicobacter pylori colonizes the stomach and causes disease, and summarizes non-pharmacological treatment methods and their mechanisms. The abstract says the bacterium is the major cause of chronic gastritis, peptic ulcer and gastric cancer. It says standard treatment combines antibiotics with proton pump inhibitors, but growing antibiotic resistance limits how well this works. The methods covered are probiotics, an oxygen-rich environment or hyperbaric oxygen therapy, antibacterial photodynamic therapy, nanomaterials, antimicrobial peptide therapy, phage therapy and modified lysins. The abstract gives no figures, no hyperbaric pressure, and no session counts, and it reports no results for any single method.
What This Means for Canadian Patients
The abstract names hyperbaric oxygen therapy as one of several non-drug approaches that are expected to help address antibiotic resistance, and it says these approaches may become a new strategy. It does not say how well hyperbaric oxygen works for Helicobacter pylori, and it gives no treatment protocol. Patients with this infection should keep following the care plan from their own doctor.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a review that summarizes existing work, and the abstract reports no pooled data or patient outcomes, so it cannot show whether hyperbaric oxygen or any other listed method works in people.